Alector, Inc.

Alector, Inc.verified

ALEC

Price:

$2.2

Market Cap:

$215.45M

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's...[Read more]

Industry

Biotechnology

IPO Date

2019-02-07

Stock Exchange

NASDAQ

Ticker

ALEC

The ROE as of December 2024 (TTM) for Alector, Inc. (ALEC) is -108.77%

According to Alector, Inc.’s latest financial reports and current stock price. The company's current ROE is -108.77%. This represents a change of 287.63% compared to the average of -28.06% of the last 4 quarters.

Alector, Inc. (ALEC) Historical ROE (quarterly & annually)

How has ALEC ROE performed in the past?

The mean historical ROE of Alector, Inc. over the last ten years is -13.95%. The current -108.77% ROE has changed 679.80% with respect to the historical average. Over the past ten years (40 quarters), ALEC's ROE was at its highest in in the September 2021 quarter at 37.69%. The ROE was at its lowest in in the September 2024 quarter at -35.50%.

Quarterly (TTM)
Annual

Average

-13.95%

Median

-30.28%

Minimum

-97.19%

Maximum

62.42%

Alector, Inc. (ALEC) ROE by Quarter and Year

Discovering the peaks and valleys of Alector, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 567.34%

Maximum Annual ROE = 62.42%

Minimum Annual Increase = -195.54%

Minimum Annual ROE = -97.19%

Quarterly (TTM)
Annual
YearROEChange
2023-97.19%56.34%
2022-62.17%567.34%
2021-9.32%-86.38%
2020-68.39%33.44%
2019-51.25%-195.54%
201853.64%-14.06%
201762.42%2.89%

Alector, Inc. (ALEC) Average ROE

How has ALEC ROE performed in the past?

The current ROE of Alector, Inc. (ALEC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-56.22%

5-year avg

-57.66%

10-year avg

-13.95%

Alector, Inc. (ALEC) ROE vs. Peers

How is ALEC’s ROE compared to its peers?

Alector, Inc.’s ROE is greater than Passage Bio, Inc. (-72.53%), greater than Black Diamond Therapeutics, Inc. (-68.08%), greater than TCR2 Therapeutics Inc. (-71.90%), greater than Harpoon Therapeutics, Inc. (-19.66%), greater than Revolution Medicines, Inc. (-33.67%), greater than Atreca, Inc. (-199.88%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than Homology Medicines, Inc. (-100.91%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Cabaletta Bio, Inc. (-50.10%), greater than Larimar Therapeutics, Inc. (-35.87%),

Build a custom stock screener for Alector, Inc. (ALEC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alector, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alector, Inc. (ALEC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alector, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Alector, Inc.'s ROE?

How is the ROE calculated for Alector, Inc. (ALEC)?

What is the highest ROE for Alector, Inc. (ALEC)?

What is the 3-year average ROE for Alector, Inc. (ALEC)?

What is the 5-year average ROE for Alector, Inc. (ALEC)?

How does the current ROE for Alector, Inc. (ALEC) compare to its historical average?